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In This IssueHost Proteins under the Influenza of H1N1
PAGE 1243 and PAGE 1255
Two studies in this issue offer new insights into how H1N1 influenza interacts with human host cells during infection. By per-
forming a functional genomic screen, Brass et al. identify host factors required for virus replication and show that an inter-
feron-inducible family of proteins, the IFITMs, are involved in restricting viral infection. Shapira et al. develop a physical
and regulatory model of influenza-host interactions that reveals unanticipated connections between viral and host proteins
with a focus on links between viral proteins and host signaling pathways. Together, these studies advance our understanding
of host-pathogen physiology and open new avenues for therapeutic development.Microbial Mosquito Net Restricts Malaria
PAGE 1268
Wolbachia are maternally inherited intracellular bacterial symbionts that can infect
many insect species. Recently a strain of Wolbachia that reduces insect life span
has been introduced into the mosquito disease vector, Aedes aegypti. Now, Moreira
et al. report that mosquitoes carrying this strain ofWolbachia have a greatly reduced
ability to support infection with dengue and Chikungunya viruses, as well as Plasmo-
dium parasites. This Wolbachia-mediated pathogen interference might represent
a powerful approach for the control of mosquito-transmitted disease.DNA Polymerase Fiddles with Fidelity
PAGE 1279Complete DNA replication requires high-fidelity replicative polymerases, as well as specialized polymerases that can move
past DNA lesions. Most specialized polymerases have distinct sequence motifs and active-site configurations for translesion
synthesis. E. coli DNA pol II and eukaryotic Pol z are exceptions, as they resemble replicative enzymes but can catalyze low-
fidelity translesion synthesis. Now, Wang and Yang provide structural and biochemical insight into how pol II masters the
tasks of both high and low fidelity DNA synthesis.Jumonji Tells PRC2 to Sit Down and Be Quiet
PAGE 1290 and PAGE 1303
In embryonic stem cells (ESCs) and early embryos, the Polycomb-repressive complex
2 (PRC2) methylates histone H3 lysine 27 at the promoters of genes that control differ-
entiation programs, resulting in their repression. In this issue, Peng et al. and Shen
et al. demonstrate that Jumonji/Jarid2 interacts with PRC2 in ESCs. Jumonji facili-
tates chromatin targeting of PRC2 while simultaneously inhibiting its enzymatic
activity, in this way regulating the balance between self-renewal and differentiation.
These studies reveal a new paradigm in the dynamics of epigenetic regulation and
how it preserves expression plasticity in stem cells.Mutant p53 Is Green and Mean
PAGE 1327
Around half of all human cancers express a mutant version of the p53 tumor-
suppressor protein that has lost the ability to suppress tumor growth. These mutant
p53 versions can contribute to a more aggressive and invasive cancer phenotype.
Here, Muller et al. show that p53 mutant proteins promote integrin and EGFR recycling through a mechanism that depends
on Rab-coupling protein. This activity correlates with the ability to inactivate the p53-related protein p63 and reveals potential
new therapeutic targets for cancer therapy.Cell 139, December 24, 2009 ª2009 Elsevier Inc. 1199
For Tumors, What Goes Around Comes Around
PAGE 1315
Tumor progression and metastasis is usually viewed as a one way road: tumor cells
leave the tumor to seed metastasis at a distant site. However, Kim et al. now show
that disseminated cancer cells can also colonize their tumor of origin in a process
the authors call ‘‘self-seeding.’’ They show that disseminated cancer cells are
attracted by tumor-derived factors. Furthermore, self-seeding can enhance tumor
growth, angiogenesis, and stromal recruitment in a breast cancer model. Their find-
ings reveal a mechanism for enrichment of tumors with metastatic cells and suggest
ways to interfere with this process by means of targeted drugs.Dynamin Bends the Rules
PAGE 1342The fission and fusion of membranes is a mechanically demanding process for the cell. Proteins of the dynamin GTPase
superfamily mediate these processes by forcing membranes into extreme curvature. By generating a molecular model of
a bacterial dynamin-like protein (BDLP) filament coating a lipid tube, Low et al. dissect the mechanism of assembly and
show how it is coupled to membrane curvature. The results suggest that nucleotide hydrolysis is coupled to dynamin polymer
disassembly and dissociation from lipid rather than membrane restructuring and have broad ramifications for dynamin family
members and NTPase lipid binding proteins.Itching to Find Receptors
PAGE 1353
Itch sensation can be triggered by histamine, but many itches are histamine indepen-
dent. Now Liu et al provide insight into the molecular basis of histamine-independent
itch, showing that members of a family of G protein-coupled receptors, Mrgprs,
function to mediate the itch commonly triggered by the antimalarial drug chloroquine.
The authors provide evidence that the expression of Mrgprs defines a subset of
sensory neurons involved in itch sensation and may thus constitute novel targets
for anti-itch therapeutics.mRNA and Protein See Growth Differently
PAGE 1366
Gene expression in bacteria depends on cellular growth rate in addition to specific regulatory mechanisms. The abundance of
macromolecular componentswithin cells—for instance, polymerases and ribosomes—depends on the cell’s growth rate, and
those dependencies differ. Klumpp et al. use computational and experimental approaches to show that the impact of growth
on genetic circuits can be predicted on the basis of these different dependencies. The findings speak to a need for careful
evaluation of gene expression studies so as to account for the different effects of growth on global mRNA and protein levels.
The results also suggest a mechanism whereby growth may contribute to a feedback mechanism affecting antibiotic resis-
tance and bacterial persistence.Cell 139, December 24, 2009 ª2009 Elsevier Inc. 1201
